Aardvark Therapeutics Inc. share price logo

Aardvark Therapeutics Inc.

NASDAQ: AARD

Small Cap

$3.78

-0.04

(-1.05%)

Live

as on

Aardvark Therapeutics Inc. Stock Performance

as on June 19, 2026 at 2:07 am IST

  • Day's Low

    Day's High

    $3.77
    $3.96
    downward going graph

    0.26%

    Downside

    4.76%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $3.35
    $17.94
    downward going graph

    11.38%

    Downside

    374.60%

    Upside

    downward going graph

Aardvark Therapeutics Inc. share price movements today

Previous Close
$3.82
Open
$3.90
Volume
20.1K
Day's Low - High
$3.77 - $3.96
52 Week Low - High
$3.35 - $17.94

Aardvark Therapeutics Inc. Historical Returns

1 Month Return
-12.39 %
3 Month Return
-21.72 %
1 Year Return
-68.38 %
3 Year Return
0 %
5 Year Return
0 %

Aardvark Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Aardvark Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$83.8M

EPS (TTM)

-3.6511

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-58.79%

Aardvark Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Aardvark Therapeutics Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
NA$83.8MNANA0.00%NA
BUY$37.6B59.83%71.0112.55%NA
BUY$115.0B144.34%26.8835.51%NA
BUY$64.4B13.01%15.0229.65%0.58%

Stock Returns calculator for Aardvark Therapeutics Inc. Stock including INR - Dollar returns

The Aardvark Therapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Aardvark Therapeutics Inc. investment value today

Current value as on today

₹34,149

Returns

-₹65,851

(-65.85%)

Returns from Aardvark Therapeutics Inc. Stock

-₹68,709 (-68.71%)

Dollar Impact

₹2,858 (+2.86%)

Indian Investors' Interest in Aardvark Therapeutics Inc. Stock

Search interest for Aardvark Therapeutics Inc. Stock has decreased by -36% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-36% versus previous 30 day period

Aardvark Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
-
0
-
0
0
0
Operating Income
-2
-2
-6
-5
-9
-10
-15
-17
-18
-22
EBITDA
-2
-2
-6
-4
-8
-9
-14
-16
-17
-21
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-2
-2
-5
-4
-8
-9
-14
-16
-17
-21
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-2
-2
-5
-4
-8
-9
-14
-16
-17
-21
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Aardvark Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
Gross Profit
0
0
0
0
Operating Income
-11
-7
-22
-62
EBITDA
-10
-6
-22
-57
Interest Expense
-
-
-
-
Depreciation
0
0
0
0
Income Before Tax
-13
-7
-20
-57
Income Tax Expense
-
-
-
-
Net Income
-13
-7
-20
-57
Net Profit Margin
0.00%
0.00%
0.00%
0.00%

Aardvark Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-2
-5
-4
-8
-9
-14
-16
-17
-21
Operating Cash Flow
-2
-4
-3
-7
-11
-9
-18
-14
-18
Investing Cash Flow
0
0
0
-11
-112
9
29
24
34
Financing Cash Flow
-
82
0
-1
88
0
2
-2
0
Change in Cash
-2
78
-3
-20
-35
0
13
7
15

Aardvark Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2023
Dec 2024
Dec 2025
Net Income
-7
-20
-57
Operating Cash Flow
-5
-18
-54
Investing Cash Flow
-
-11
-49
Financing Cash Flow
-
81
89
Change in Cash
-5
51
-14

Global Institutional Holdings in Aardvark Therapeutics Inc.

Funds
Holdings
LAURION CAPITAL MANAGEMENT LP
4.74%
Polygon Management Ltd
1.45%
Adage Capital Partners Gp LLC
1.38%
Millennium Management LLC
0.45%
Northern Trust Corp
0.41%

Insights on Aardvark Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 18.4% return, outperforming this stock by 86.8%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 6 months, AARD stock has moved down by -72.1%

About Aardvark Therapeutics Inc.

Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.
OrganisationAardvark Therapeutics Inc.
Headquarters4370 La Jolla Village Drive, San Diego, CA, United States, 92122
IndustryBiotechnology
CEODr. Tien-Li Lee M.D.
E-voting on sharesClick here to vote

Key Management of Aardvark Therapeutics Inc.

Name

Title

Mr. Ron Lewis II, Ph.D.

VP & Head of CMC

Mr. Justin T. Stege Ph.D.

VP and Head of Project Management & Strategy

Dr. Timothy J. Kieffer Ph.D.

Chief Scientific Officer

Mr. Christian Zapf J.D.

General Counsel

Dr. Zhenhuan Zheng Ph.D.

Chief Research Officer

Dr. Dvorit Samid Ph.D.

Executive Vice President of Medical Affairs

Mr. Danny Villeneuve

Chief Commercial Officer

Dr. Tien-Li Lee M.D.

CEO, Secretary & Director

Mr. Nelson B. Sun M.B.A.

CFO & COO

Dr. Manasi Sinha Jaiman M.D., M.P.H.

Chief Medical Officer

FAQs

What is Aardvark Therapeutics Inc. share price today?

Aardvark Therapeutics Inc. share price today is $3.78 as on . Aardvark Therapeutics Inc. share today touched a day high of $3.96 and a low of $3.77.

What is the 52 week high and 52 week low for Aardvark Therapeutics Inc. share?

Aardvark Therapeutics Inc. share touched a 52 week high of $17.94 on and a 52 week low of $3.35 on . Aardvark Therapeutics Inc. stock price today i.e. is trending at $3.78,which is 78.93% down from its 52 week high and 12.84% up from its 52 week low.

What is Aardvark Therapeutics Inc.'s market capitalisation today?

Aardvark Therapeutics Inc. market capitalisation is $0.00T as on .

How to invest in Aardvark Therapeutics Inc. Stock (AARD) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Aardvark Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Aardvark Therapeutics Inc. Shares that will get you 0.3968 shares as per Aardvark Therapeutics Inc. share price of $3.78 per share as on June 18, 2026 at 8:37 pm IST.

What is the minimum amount required to buy Aardvark Therapeutics Inc. Stock (AARD) from India?

Indian investors can start investing in Aardvark Therapeutics Inc. (AARD) shares with as little as ₹94.323 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹943.23 in Aardvark Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Aardvark Therapeutics Inc. share’s latest price of $3.78 as on June 18, 2026 at 8:37 pm IST, you will get 2.6455 shares of Aardvark Therapeutics Inc.. Learn more about fractional shares .